Literature DB >> 12088061

Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma.

Sacide Altinöz1, Emirhan Nemutlu, Sedef Kir.   

Abstract

Meloxicam is a new non-steroidal anti-inflammatory drug (NSAID), which has a higher activity cyclooxygenase-2 (COX-2) than against cyclooxygenase-1 (COX-1), with potentially high anti-inflammatory and analgesic action. The voltammetric behaviour of meloxicam was studied using direct current (DC), differential pulse polarography (DPP) and cyclic voltammetry (CV). The influence of several variables (including nature of the buffer, pH, concentration, modulation amplitude, scan rate, drop size, etc.) was examined in DPP method for meloxicam. The best DPP response was obtained in acetate buffer pH 4.88. The peak currents were measured with a static mercury drop electrode at -1.49 V versus Ag/AgCl. Calibration curve for meloxicam was linear at a concentration range from 0.38 to 15.0 microg ml(-1). The method was validated and applied to the determination of meloxicam in tablets, which were in two different dosage forms. A spectrophotometric method reported in the literature was utilized as a comparison method. There were no significant differences between the results obtained by two methods. DPP method is also available and applicable for the determination of mentioned substance in plasma. Mean recovery was 99.20+/-0.37%. It was concluded that the developed method was accurate, sensitive, precise, reproducible and useful for the quality control of meloxicam in pharmaceuticals and spiked plasma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088061     DOI: 10.1016/s0014-827x(02)01239-9

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  Optimization of photocatalytic degradation of meloxicam using titanium dioxide nanoparticles: application to pharmaceutical wastewater analysis, treatment, and cleaning validation.

Authors:  Ahmed H Nadim; Medhat A Al-Ghobashy; Marianne Nebsen; Mostafa A Shehata
Journal:  Environ Sci Pollut Res Int       Date:  2015-05-27       Impact factor: 4.223

Review 2.  Analgesia for Sheep in Commercial Production: Where to Next?

Authors:  Alison Small; Andrew David Fisher; Caroline Lee; Ian Colditz
Journal:  Animals (Basel)       Date:  2021-04-14       Impact factor: 2.752

3.  Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC.

Authors:  Nalini Kanta Sahoo; Madhusmita Sahu; Podilapu Srinivasa Rao; N Sandhya Rani; Jnv Indira Devi; Goutam Ghosh
Journal:  Springerplus       Date:  2014-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.